Brazil's Anvisa Maintains Ban on E-Cigarettes

Jul.11.2022
Brazil's Anvisa Maintains Ban on E-Cigarettes
Brazil's Anvisa decided to maintain the ban on e-cigarettes, with plans to enforce it better and reduce demand.

The Brazilian federal health regulatory agency, Anvisa, has voted to maintain the ban on electronic cigarettes in the country that has been in place since 2009.

 

The board members agreed to continue prohibiting the sales, imports and marketing of electronic cigarette products. They also approved further discussions on how to improve the implementation of the ban and reduce the demand for electronic cigarettes in the future.

 

The meeting lasted for over four hours, during which government officials, experts, and activists gave speeches. Only one person opposed the ban - a lawyer from Phimo International.

 

Despite the ban, electronic cigarettes are becoming increasingly popular in Brazil, particularly among young people. A recent telephone survey revealed that smokers make up approximately 12% of the country's total population, while 20% of Brazilians aged 18 to 24 use e-cigarettes.

 

The World Health Organization (WHO) has issued a warning in their latest global report on tobacco use, stating that e-cigarettes are becoming a gateway for young people to start using other nicotine products, such as traditional cigarettes.

 

This article is compiled from third-party information and is intended for educational purposes and communication only. The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.

 

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Fiscal benefit, not health, strongest indicator for vape bans – Contributed by Samrat Chowdhery
Fiscal benefit, not health, strongest indicator for vape bans – Contributed by Samrat Chowdhery
Data shows 75% of nations with state stakes in tobacco trade ban modern substitutes compared to 10% in the free-market group. What is driving these divergent regulations?
Feb.04
Arizona’s Operation Counter Strike Conducts 1,882 Tobacco Retailer Inspections in Fiscal 2025, Issues 451 Criminal Citations
Arizona’s Operation Counter Strike Conducts 1,882 Tobacco Retailer Inspections in Fiscal 2025, Issues 451 Criminal Citations
Arizona Attorney General Kris Mayes announced the results of the Attorney General’s Office “Operation Counter Strike” program on March 9, 2026.
Mar.11 by 2FIRSTS.ai
Malaysia’s Perak Health Department says seized vape-related items valued at RM2,738 during two-week operation
Malaysia’s Perak Health Department says seized vape-related items valued at RM2,738 during two-week operation
Malaysia’s Perak State Health Department said it carried out a two-week joint enforcement operation from January 1 to 14, 2026, in line with the state government’s policy prohibiting renewals of vape sales licences effective January 1.
Jan.20 by 2FIRSTS.ai
China Caps E-Cigarette Capacity and Requires Export Compliance Proof to Curb “Involution”
China Caps E-Cigarette Capacity and Requires Export Compliance Proof to Curb “Involution”
China’s top tobacco regulator has issued a directive aimed at preventing excess capacity and curbing “involution-style” competition in the e-cigarette sector. The notice tightens investment controls, formalizes verified capacity management and requires exporters to submit compliance proof for destination markets, signaling a push toward higher industry concentration and stricter cross-border oversight.
Special Report
Feb.13
TPB Q4 FY2025 Revenue Rises 29% to $121 Million; Modern Oral Business Up 266% Year Over Year
TPB Q4 FY2025 Revenue Rises 29% to $121 Million; Modern Oral Business Up 266% Year Over Year
Turning Point Brands, a U.S. nicotine and tobacco-related consumer products company, reported its fiscal 2025 fourth-quarter results: quarterly revenue was $121 million, up 29% year over year; adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) was $30 million, up 14%. Net revenue from modern oral nicotine products was $41.3 million, up 266% year over year.
Mar.03 by 2FIRSTS.ai
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Stresses “Predictability” as Science Chief Addresses Industry Uncertainty
FDA Commissioner Marty Makary briefly appeared at the February 10 PMTA roundtable, underscoring the importance of regulatory predictability. At the close of the session, Office of Science Director Matthew Farrelly responded to industry concerns over review uncertainty, stating the agency will issue a written summary of feedback, while reiterating that no fixed quantitative risk benchmark governs authorization decisions.
Feb.11